Drug Topics

SEPTEMBER 18, 2024

A co-administration option for both vaccinations can increase the likelihood of older adults completing the vaccination series and improve health outcomes for the patient population.

Vaccines 530

Vaccines 530

Drug Topics

JANUARY 7, 2025

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Vaccines 527

Vaccines Immunization 527

Drug Topics

NOVEMBER 24, 2023

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Vaccines 582

Vaccines 582

Drug Topics

SEPTEMBER 10, 2024

Researchers explored an alternative pharmacist education intervention as a way of improving pharmacist-patient conversations and decreasing vaccine hesitancy among patients.

Vaccines 503

Vaccines 503

Drug Topics

DECEMBER 7, 2022

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Vaccines 550

Vaccines 550

Drug Topics

DECEMBER 24, 2023

Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.

Vaccines 491

Vaccines Immunization 491

Drug Topics

OCTOBER 8, 2024

Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.

Vaccines 528

Vaccines 528

Drug Topics

FEBRUARY 14, 2023

The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.

Vaccines 469

Vaccines 469

Drug Topics

DECEMBER 2, 2024

Researchers addressed vaccine effectiveness for individuals with direct household contacts that reported influenza.

Vaccines 501

Vaccines 501

Drug Topics

OCTOBER 21, 2022

As vaccine hesitancy grows, fewer children are receiving routine childhood vaccines.

Vaccines 503

Vaccines 503

Drug Topics

MARCH 19, 2024

Moderna, Merck, and Pfizer-BioNTech are leading the charge with new vaccines for respiratory viruses in development.

Vaccines 498

Vaccines 498

Drug Topics

JANUARY 16, 2025

Researchers compared the safety and reactogenicity of simultaneous doses of recombinant zoster vaccine paired with 2 separate types of inactivated influenza vaccines.

Vaccines 469

Vaccines 469

Drug Topics

JUNE 17, 2024

In an attempt to promote flu vaccination, Kristen Thorson, PharmD, encourages pharmacists to “know the power of their recommendation.”

Vaccines 498

Vaccines 498

Drug Topics

OCTOBER 10, 2024

Researchers analyzed the potential role of nonphysician health care providers to provide vaccine services outside of traditional health care settings.

Vaccines 497

Vaccines 497

Drug Topics

MARCH 11, 2025

IQVIA released a report detailing pharmacists authority to administer vaccines in the US as well as adults overall vaccination rates by state.

Vaccines 405

Vaccines Immunization 405

Drug Topics

NOVEMBER 4, 2024

Ruth Carrico PhD, DNP, APRN, discussed the importance of annual vaccination and overall health awareness and literacy during the winter flu season.

Vaccines 526

Vaccines 526

Drug Topics

MARCH 27, 2024

5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine. mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5

Vaccines 530

Vaccines Immunization 530

Drug Topics

NOVEMBER 28, 2022

A recent poll showed that some parents do not discuss vaccines with their child’s regular doctor, with many choosing to not have their child receive any vaccines.

Vaccines 469

Vaccines 469

Drug Topics

MAY 19, 2023

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Vaccines 496

Vaccines 496

Drug Topics

JANUARY 10, 2024

The estimated efficacy of the vaccine against documented infection for children and adolescents during the Omicron wave was 74.3% and 85.5%, respectively.

Vaccines 548

Vaccines Documentation 548

Drug Topics

SEPTEMBER 7, 2022

When it comes to the COVID-19 vaccine, independent pharmacies are being set up to fail by federal health partners.

Independent Pharmacies 568

Independent Pharmacies Vaccines 568

Drug Topics

JANUARY 3, 2025

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Vaccines 464

Vaccines Immunization 464

Drug Topics

DECEMBER 23, 2024

Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.

Vaccines 469

Vaccines 469

Drug Topics

FEBRUARY 21, 2023

With nearly 250,000 kindergarten age children not receiving their recommended vaccines, pediatric health care providers search for solutions.

Vaccines 467

Vaccines 467

Drug Topics

NOVEMBER 15, 2024

After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.

Vaccines 469

Vaccines 469

Drug Topics

SEPTEMBER 7, 2022

Keep your pharmacy vaccine-ready for your youngest patients with the most current influenza vaccination information from the American Academy of Pediatrics.

Vaccines 503

Vaccines 503

Drug Topics

OCTOBER 15, 2023

Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed the new vaccine guidelines from ACIP. Jean-Venable R.

Vaccines 551

Vaccines 551

Drug Topics

SEPTEMBER 11, 2023

Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.

Vaccines 524

Vaccines FDA 524

Drug Topics

FEBRUARY 2, 2024

The vaccine showed an overall efficacy of 80% in the per-protocol analysis, with a risk reduction of 6.1 typhoid infections per 1000 vaccinated children.

Vaccines 468

Vaccines 468

Drug Topics

OCTOBER 30, 2023

Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.

Vaccines 503

Vaccines 503

Drug Topics

MARCH 13, 2024

Since changes in vaccine composition can sometimes lead to confusion or misinformation, effective communication is crucial to promote vaccine uptake.

Vaccines 503

Vaccines Communication 503

Drug Topics

SEPTEMBER 9, 2022

Address vaccine hesitancy at your pharmacy to encourage patients and their families to get vaccinated against COVID-19, flu, and more.

Vaccines 503

Vaccines 503

Drug Topics

JANUARY 30, 2023

The shots should still be free to individuals because of rules barring out-of-pocket costs for such vaccinations. Pfizer Inc. and Moderna Inc. have indicated that they are going to price their shots at between $110 and $130.

Vaccines 501

Vaccines 501

Drug Topics

OCTOBER 31, 2023

The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.

Vaccines 502

Vaccines Immunization 502

Drug Topics

DECEMBER 1, 2022

Although it’s safe and recommended to co-administer these shots, research finds a reduction in flu vaccine uptake the following year.

Vaccines 469

Vaccines 469

Drug Topics

JANUARY 5, 2024

A model showed that if a vaccine coverage of 66% were achieved—similar to flu vaccination coverage—it could have a budget impact of $6.48 billion over the first RSV season.

Vaccines 497

Vaccines 497

Drug Topics

FEBRUARY 15, 2024

Innovation in the vaccine area continues. In 2023, the FDA approved six vaccines, including several important firsts. But they face a difficult landscape where federal policies dictate coverage.

Vaccines 461

Vaccines Insurance FDA 461